Idiopathic Thrombocytopenic Purpura (ITP) is a rare autoimmune disorder characterized by low platelet count, leading to excessive bleeding and bruising. The prevalence of ITP varies across different populations, with an estimated incidence of 3.3 to 9.5 cases per 100,000 individuals per year. It is more common in children, especially between the ages of 2 and 10, with a peak incidence of 5.3 cases per 100,000 children per year. However, ITP can also affect adults, with an estimated prevalence of 9.5 cases per 100,000 individuals per year in the general adult population.
Idiopathic Thrombocytopenic Purpura (ITP) is a rare autoimmune disorder characterized by a low platelet count, leading to excessive bleeding and bruising. The prevalence of ITP varies across different populations and age groups.
According to available data, the estimated prevalence of ITP is around 9.5 to 10.8 cases per 100,000 adults and 5.3 to 6.4 cases per 100,000 children. However, it is important to note that these figures may not capture the full extent of the condition, as milder cases may go undiagnosed or unreported.
ITP can affect individuals of any age, but it is more commonly diagnosed in children and young adults. The exact cause of ITP is unknown, hence the term "idiopathic." It is believed to involve the immune system mistakenly attacking and destroying platelets, leading to their reduced numbers.
While ITP is considered a rare disorder, it can have a significant impact on the quality of life for those affected. Prompt diagnosis and appropriate management are crucial in minimizing complications and ensuring the well-being of individuals living with ITP.